Showing 341 - 360 results of 438 for search '"hepatitis C"', query time: 0.08s Refine Results
  1. 341

    Elastography in Hepatology by Ludovico Abenavoli, Christophe Corpechot, Raoul Poupon

    Published 2007-01-01
    “…Currently, there are only a few studies that have evaluated TE effectiveness in chronic liver diseases, mostly in patients infected with the hepatitis C virus. Further studies are needed in patients with chronic liver disease, to assess the effectiveness of the fibrosis treatment.…”
    Get full text
    Article
  2. 342

    Prevalence of anaemia and the associated factors among hospitalised people living with HIV receiving antiretroviral therapy in Southwest China: a cross-sectional study by Jie Yuan, Hai Long, Min Liu, Juan He, Jue Liu, Yu Wu, Wenzhan Jing, Min Du, Manna Zhang, Yaping Wang, Su Song, Siqi Liu, Guiying Cao, Yuedong Liang, Xiaoxin Xie, Yanhua Fu

    Published 2022-07-01
    “…Female sex, those widowed or divorced, and thrombocytopenia were associated with increased odds of anaemia, and those widowed or divorced, thrombocytopenia and hepatitis C were associated with increased odds of severe anaemia. …”
    Get full text
    Article
  3. 343

    Acute Sickle Hepatic Crisis after Liver Transplantation in a Patient with Hb SC Disease by J. H. Gillis, S. K. Satapathy, L. Parsa, P. B. Sylvestre, N. Dbouk

    Published 2015-01-01
    “…We describe the case of a patient with a history of hemoglobin SC disease and cirrhosis caused by hepatitis C presenting approximately 1 year after liver transplantation with an ASHC. …”
    Get full text
    Article
  4. 344

    Incidence of Severe Hepatotoxicity Related to Antiretroviral Therapy in HIV/HCV Coinfected Patients by Emily L. Heil, Mary L. Townsend, Kenneth Shipp, Amy Clarke, Melissa D. Johnson

    Published 2010-01-01
    “…Hepatotoxicity is a concern in HIV/hepatitis C virus (HCV) coinfected patients due to their underlying liver disease. …”
    Get full text
    Article
  5. 345

    Alaninaminotransferase and specific viral hepatitis markers in the blood of donors by Zh. K. Burkitbayev, G. A. Yesenbayeva, S. A. Abdrakhmanova, Zh. Zh. Bibekov, Ye. B. Zhiburt

    Published 2018-08-01
    “…In the samples received after capillary blood culling the anti-hepatitis C virus antibodies positivity rate was decreased. …”
    Get full text
    Article
  6. 346

    The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence by Goran B. Klintmalm, Björn Nashan

    Published 2014-01-01
    “…Despite the success of liver transplantation, long-term complications remain, including de novo malignancies, metabolic syndrome, and the recurrence of hepatitis C virus (HCV) and hepatocellular carcinoma (HCC). …”
    Get full text
    Article
  7. 347

    RNA Viruses: ROS-Mediated Cell Death by Mohammad Latif Reshi, Yi-Che Su, Jiann-Ruey Hong

    Published 2014-01-01
    “…This review focuses on RNA viruses and retroviruses, giving particular attention to the human influenza virus, Hepatitis c virus (HCV), human immunodeficiency virus (HIV), and the aquatic Betanodavirus. …”
    Get full text
    Article
  8. 348

    Reversible Pulmonary Arterial Hypertension Associated with Interferon-Beta Treatment for Multiple Sclerosis by E Gibbons, S Promislow, RA Davies, G Chandy, DJ Stewart, V Contreras-Dominguez, C Pugliese, R Dunne, LM Mielniczuk

    Published 2015-01-01
    “…Interferon (IFN) therapy has an important role in the treatment of multiple sclerosis and chronic hepatitis C infection. A few case reports have described an association between IFN therapy and the development of irreversible pulmonary arterial hypertension (PAH), and it is currently listed as a possible drug-induced cause of PAH in the most recent classification of pulmonary hypertension. …”
    Get full text
    Article
  9. 349

    Multiple Comorbid Conditions among Middle-Aged and Elderly Hemophilia Patients: Prevalence Estimates and Implications for Future Care by Aroub A. Khleif, Nidra Rodriguez, Deborah Brown, Miguel A. Escobar

    Published 2011-01-01
    “…The most common conditions identified were chronic hepatitis C, hypertension, HIV, chronic arthropathy, and overweight/obesity. …”
    Get full text
    Article
  10. 350

    Efficacy Comparison of Nitazoxanide Combined with Lactulose versus Lactulose Monotherapy in Managing Overt Hepatic Encephalopathy by Taimoor Hafeez Janjua, Amanat Ali, Sameer Ahmed, Sabeen Shakir, Zunera Rashid, Asma Irfan

    Published 2025-01-01
    “…Results: A total of 150 patients, with a mean age of 44.08 ± 11.31 years were enrolled. Hepatitis C was the predominant aetiology in 81 patients (54%). …”
    Get full text
    Article
  11. 351

    3-(5-Hydroxyphenyl)-5-Phenyl-2-Pyrazolines as Toll-Like Receptor 7 Agonists by Ji Hwan Kim, Seunghyun Ahn, Dongsoo Koh, Young Han Lee, Yoongho Lim, Soon Young Shin

    Published 2023-01-01
    “…Toll-like receptor 7 (TLR7) is an attractive target for developing immune modulators to enhance innate immunity against ssRNA virus infections, including hepatitis C and COVID-19. Ten 3-(5-hydroxyphenyl)-5-phenyl-2-pyrazolines were tested using TLR7 reporter cells, overexpressing TLR7 and the NF-κB-inducible SEAP reporter gene to discover a novel TLR7 agonist enhancing innate immunity. …”
    Get full text
    Article
  12. 352

    Concomitant Nephrotic Syndrome and Cryoglobulinemia in a Case of Malignant Mesothelioma by Kei Nagai, Hiroaki Tachi, Kohei Inoue, Atsushi Ueda

    Published 2022-01-01
    “…Cryoglobulinemia is found in various pathological statuses, such as hepatitis C virus infection but rarely in malignant neoplasms. …”
    Get full text
    Article
  13. 353

    Hepatocellular Carcinoma to the Right Ventricle by George R. Marzouka, Apurva Badheka, Alexis P. Rodriguez, Sandra V. Chaparro

    Published 2014-01-01
    “…We present a case of a 63-year-old man with history of hepatitis C and cirrhosis, which had progressed to HCC. …”
    Get full text
    Article
  14. 354

    Assessment of Some Heavy Metals and Trace Elements in a Sample of Patients with Viral Hepatitis in Baghdad by Najlaa Fattah-Allah Rasheed, Hind Salman Jassim, Ahmad Saadi Hassan

    Published 2022-09-01
    “…One hundred fifty samples of blood were collected from fifty patients with hepatitis B, fifty patients with hepatitis C, and fifty individuals without viral hepatitis as controls at the Gastroenterology and Hepatology Teaching Hospital in Baghdad during the period from November 2021 to March 2022. …”
    Get full text
    Article
  15. 355

    Challenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited Settings by Wirach Maek-a-Nantawat, Anchalee Avihingsanon, Pirapon June Ohata

    Published 2012-01-01
    “…Most of the patients infected with hepatitis C in Thailand have genotype 3 which is significantly related to intravenous drug use whereas, in Vietnam, it is genotype 6. …”
    Get full text
    Article
  16. 356

    Role of Interleukin-28B in clearance of HCV in acute and chronic hepatitis patients in Kirkuk city by Muhannad Abdullah Alazzawy

    Published 2018-07-01
    “…The number of hepatitis patient understudy were 62 hepatitis C (27 acute and 35 chronic) whose ages were between 20-75 years old. …”
    Get full text
    Article
  17. 357

    Bardet-Biedl Syndrome with a Kidney Transplant, Esophageal Adenocarcinoma, and Postoperative Complications by Georgi Yankov, Teodora Mihalova, Rosen Petkov, Evgeni Mekov, Stefka Yankova, Danail Petrov

    Published 2019-01-01
    “…The authors present a rare clinical case of a patient with Bardet-Biedl syndrome and chronic kidney disease, who reached end-stage renal disease (ESRD) and underwent a long-term hemodialysis treatment, during which infections with Hepatitis C Virus (HCV) infection and Cytomegalovirus (CMV) infection were established. …”
    Get full text
    Article
  18. 358

    Cytokines and HCV-Related Disorders by Poupak Fallahi, Clodoveo Ferri, Silvia Martina Ferrari, Alda Corrado, Domenico Sansonno, Alessandro Antonelli

    Published 2012-01-01
    “…Cytokines are intercellular mediators involved in viral control and liver damage being induced by infection with hepatitis C virus (HCV). The complex cytokine network operating during initial infection allows a coordinated, effective development of both innate and adaptive immune responses. …”
    Get full text
    Article
  19. 359

    Simeprevir and Sofosbuvir Combination Treatment in a Patient with HCV Cirrhosis and HbS Beta 0-Thalassemia: Efficacy and Safety despite Baseline Hyperbilirubinemia by Nikolaos Papadopoulos, Melanie Deutsch, Athanasios Georgalas, Helias Poulakidas, Lazaros Karnesis

    Published 2016-01-01
    “…We describe a 51-year-old female patient with HbS beta 0-thalassemia and recently diagnosed compensated cirrhosis due to chronic hepatitis C infection. Laboratory evaluation revealed total bilirubin: 2.7 mg/dL and serum HCV-RNA 137.204 IU/mL. …”
    Get full text
    Article
  20. 360

    HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A Concurrent Pathogenetic Role by Giuseppe Sautto, Nicasio Mancini, Laura Solforosi, Roberta A. Diotti, Massimo Clementi, Roberto Burioni

    Published 2012-01-01
    “…The association between hepatitis C virus (HCV) infection and type II mixed cryoglobulinemia (MCII) is well established, but the role played by distinct HCV proteins and by specific components of the anti-HCV humoral immune response remains to be clearly defined. …”
    Get full text
    Article